Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapy - Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapy

Toho University Graduate School of Medicine0 个研究点目标入组 25 人开始时间: 2014年2月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)patients previously treated with Nab-paclitaxel,paclitaxel derivative drugs 2)peripheral neuropathy 3)History of serious drug hypersensitivity 4)active synchronous malignancy with longer than 5 year interval period 5)Uncontrolled unstable angina, congestive heart failure, myocardial infarction or ventricular arrhythmia 6)Any other serious illness or medical conditions including interstitial pneumonia or pulmonary fibrosis, renal failure, liver failure,cerebrovascular disordar or Uncontrolled diabates 7)Active infection or fever suspicious of infection. 8)The case that uses a steroid regularly 9)Much amount of pleural effusion, ascites or cardiac effusion 10)Case having extensive bone metastasis 11)with brain metastasis 12)History of mental disorder, central nerve disorder 13)Pregnant women, nursing mothers 14)Patients who were considered by the primary care physician to be inappropriate for this trial

发起方

Toho University Graduate School of Medicine